Literature DB >> 10772128

Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin.

O Maeda1, H Iwase, N Mamiya, M Nakamura, T Mizuno, Y Nishio, T Ando, K Ina, K Kusugami.   

Abstract

A 68-year-old man was diagnosed as having a scirrhous cancer of the stomach. Carcinomatous peritonitis was suspected on abdominal CT examination. Three courses of uracil and tegafur (UFT)/cisplatin (CDDP) chemotherapy were administered. The primary foci were reduced in size, then total gastrectomy was performed. Histological findings revealed a poorly differentiated adenocarcinoma with scirrhous invasion into the subserosa. Histological efficacy of the chemotherapy was judged to be grade 2. The patient has been alive without disease for more than five years after total gastrectomy. Neoadjuvant chemotherapy with UFT and CDDP may have contributed to the favorable clinical outcome in this patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772128     DOI: 10.2169/internalmedicine.39.239

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Neoadjuvant chemotherapy with S-1 for scirrhous gastric cancer: a pilot study.

Authors:  Taira Kinoshita; Masaru Konishi; Toshio Nakagohri; Kazuo Inoue; Tatsuya Oda; Shinichiro Takahashi; Narikazu Boku; Atsushi Ohtsu; Shigeaki Yoshida
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

2.  Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002).

Authors:  Taira Kinoshita; Mitsuru Sasako; Takeshi Sano; Hitoshi Katai; Hiroshi Furukawa; Akira Tsuburaya; Isao Miyashiro; Masahide Kaji; Motoki Ninomiya
Journal:  Gastric Cancer       Date:  2009-04-24       Impact factor: 7.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.